Zobrazeno 1 - 10
of 78
pro vyhledávání: '"Kenneth Webster"'
Autor:
Shichang Miao, Peter Staehr, Ezra Tai, Borje Darpo, Hongqi Xue, Danielle Armas, Kenneth Webster, Rajneet K. Oberoi
Publikováno v:
Clinical and Translational Science, Vol 17, Iss 7, Pp n/a-n/a (2024)
Abstract This phase I thorough QTc, double‐blind, randomized, placebo‐ and positive‐controlled, parallel group, multiple‐dose study evaluated avacopan's effect on cardiac repolarization using concentration‐QTc (C‐QTc) as the primary analy
Externí odkaz:
https://doaj.org/article/a9cf4106b51344e988533b466eaadf9d
Autor:
D. Scott McMeekin, Kenneth Webster, Kathleen M. Darcy, Doris M. Benbrook, Steven E. Waggoner, Deborah J. Stearns-Kurosawa, Michael W. Sill
Publikováno v:
Gynecologic Oncology. 106:596-603
Objectives To evaluate the efficacy and adverse events (AEs) of thalidomide in previously treated, measurable, persistent or recurrent leiomyosarcoma (LMS) of the uterus, and to explore associations between angiogenic markers and treatment or clinica
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 131:581-584
Purpose To evaluate the efficacy and safety of the combination of carboplatin plus paclitaxel in patients with advanced, metastatic and recurrent endometrial cancer. Methods Medical records were retrospectively reviewed to identify endometrial cancer
Autor:
Kenneth Webster, Maurie Markman, Kristine M. Zanotti, Jerome L. Belinson, Gertrude Peterson, Barbara Kulp, Jon Markman
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 130:741-744
There are limited data available in the oncology literature regarding the risk of thrombocytopenia associated with carboplatin-based second-line treatment of ovarian cancer, outside the setting of patients participating in clinical trials. To examine
Autor:
Jerome L. Belinson, Kenneth Webster, Barbara Kulp, Gertrude Peterson, Maurie Markman, Kristine M. Zanotti
Publikováno v:
Gynecologic Oncology. 94:404-408
Objectives . A previously reported phase 2 trial suggested substantial clinical activity associated with the combination of a platinum agent and tamoxifen in the treatment of platinum-resistant ovarian cancer. We wished to confirm or refute this obse
Autor:
Gertrude Peterson, Jerome L. Belinson, Barbara Kulp, Jonathan Markman, Kenneth Webster, Maurie Markman, Kristine M. Zanotti
Publikováno v:
Journal of Clinical Oncology. 22:3120-3125
Purpose Limited information is available regarding the influence of the duration of a prior response on the length of a subsequent response to platinum chemotherapy in recurrent ovarian cancer. Patients and Methods We retrospectively reviewed the med
Publikováno v:
Gynecologic Oncology. 93:390-393
Objectives . Tamoxifen, a well-tolerated oral hormonal agent with biological activity in ovarian cancer, is a potentially attractive option in asymptomatic patients with recurrent disease. Unfortunately, the clinical utility of the drug in this speci
Autor:
Kenneth Webster, Daniel J. Lindner, Maurie Markman, Kristine M. Zanotti, Bei H. Morrison, Jerome L. Belinson, Ernest C. Borden, Barbara S. Jacobs
Publikováno v:
Oncology. 66:343-346
Objective: The protocol was designed to examine the biological effects and clinical activity of interferon-β in patients with platinum/taxane-resistant ovarian cancer. Methods: Patients with resistant ovarian and fallopian tube cancers and primary p
Autor:
Jerome L. Belinson, Pedro F. Escobar, Kenneth Webster, Maurie Markman, Kristine M. Zanotti, Peter G. Rose
Publikováno v:
Gynecologic Oncology. 92:192-196
Objective . Our goal in this nonrandomized phase 2 trial was to evaluate the toxicity and obtain preliminary data on the potential efficacy of a novel three-drug combination regimen (carboplatin–paclitaxel–irinotecan) when employed as initial the